Triple
T2190751
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Janssen COVID-19 Vaccine |
E49854
|
entity |
| Predicate | usesViralVector |
P37227
|
FINISHED |
| Object |
human adenovirus serotype 26 (Ad26)
Human adenovirus serotype 26 (Ad26) is a non-replicating viral vector commonly used in vaccine development to deliver genetic material encoding target antigens and stimulate an immune response.
|
E241391
|
NE FINISHED |
How this triple was built (5 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: human adenovirus serotype 26 (Ad26) | Statement: [Janssen COVID-19 Vaccine, usesViralVector, human adenovirus serotype 26 (Ad26)]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: human adenovirus serotype 26 (Ad26) Context triple: [Janssen COVID-19 Vaccine, usesViralVector, human adenovirus serotype 26 (Ad26)]
-
A.
rVSV-ZEBOV
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
-
B.
Immunix
Immunix was a security-focused software company known for developing Linux security technologies, including the precursor to the AppArmor mandatory access control system.
-
C.
Leqembi
Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
-
D.
The O2 complex
The O2 complex is a large entertainment district in London featuring the O2 Arena, cinemas, restaurants, bars, and various leisure and retail facilities housed under the iconic dome structure.
-
E.
Lextran
Lextran is the public bus transit system serving Lexington and surrounding areas in Fayette County, Kentucky.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: human adenovirus serotype 26 (Ad26) Triple: [Janssen COVID-19 Vaccine, usesViralVector, human adenovirus serotype 26 (Ad26)]
Generated description
Human adenovirus serotype 26 (Ad26) is a non-replicating viral vector commonly used in vaccine development to deliver genetic material encoding target antigens and stimulate an immune response.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: human adenovirus serotype 26 (Ad26) Target entity description: Human adenovirus serotype 26 (Ad26) is a non-replicating viral vector commonly used in vaccine development to deliver genetic material encoding target antigens and stimulate an immune response.
-
A.
rVSV-ZEBOV
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
-
B.
Immunix
Immunix was a security-focused software company known for developing Linux security technologies, including the precursor to the AppArmor mandatory access control system.
-
C.
Leqembi
Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
-
D.
The O2 complex
The O2 complex is a large entertainment district in London featuring the O2 Arena, cinemas, restaurants, bars, and various leisure and retail facilities housed under the iconic dome structure.
-
E.
Lextran
Lextran is the public bus transit system serving Lexington and surrounding areas in Fayette County, Kentucky.
- F. None of above. chosen
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: usesViralVector Context triple: [Janssen COVID-19 Vaccine, usesViralVector, human adenovirus serotype 26 (Ad26)]
-
A.
virusSubtype
Indicates the specific subtype classification of a virus within a broader virus type or strain.
-
B.
hasVector
Indicates that an entity is associated with, or can be represented by, a specific vector in some vector space.
-
C.
vaccineUsed
Indicates that a particular vaccine has been administered or applied in a given medical or experimental context.
-
D.
hasCulturalTransmission
Indicates that a cultural trait, practice, or knowledge is passed from one entity (such as an individual, group, or generation) to another.
-
E.
isMajorCarrierOf
Indicates that one entity serves as the primary or principal transporter or conveyor of another entity (such as goods, signals, or passengers).
- F. None of above. chosen
Provenance (7 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a88aaba3c48190b351cab9b26989ff |
completed | March 4, 2026, 7:40 p.m. |
| NER | Named-entity recognition | batch_69abbf9e99f08190892d34485c8f2f25 |
completed | March 7, 2026, 6:03 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ae5db0352c8190aa9c4c58460df3a4 |
completed | March 9, 2026, 5:42 a.m. |
| NEDg | Description generation | batch_69ae5e60b45c819088bf18ae564f0d1a |
completed | March 9, 2026, 5:45 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69ae5ec4a35c8190bffc7a183497e764 |
completed | March 9, 2026, 5:46 a.m. |
| PD | Predicate disambiguation | batch_69abbda32d1881909d1fd83a751fb21c |
completed | March 7, 2026, 5:54 a.m. |
| PDg | Predicate description generation | batch_69abbf9c77fc8190a323bcaf644fb2c5 |
completed | March 7, 2026, 6:03 a.m. |
Created at: March 4, 2026, 7:46 p.m.